Effect of toxic thioureas on resistance of rats to growth in the lungs of intravenously and intratracheally seeded tumour cells. by van den Brenk, H. A. et al.
Br. J. Cancer (1978) 37, 92.
EFFECT OF TOXIC THIOUREAS ON RESISTANCE OF RATS
TO GROWTH IN THE LUNGS OF INTRAVENOUSLY AND
INTRATRACHEALLY SEEDED TUMOUR CELLS
H. A. S. VAN DEN BRENK,* H. KELLY AND K. L. HOLLAND
From the Richard Dimbleby Department of Cancer Re8earch, St Thoma's Hospital Medical School,
London SE1 7EH
Received 20 June 1977 Accepted 16 August 1977
Summary.-Clonogenic growth (colony-forming efficiency, CFE) of i.v. injected
allogeneic W256 tumour cells in the lungs was markedly enhanced by treatment of
rats with x-naphthyl thiourea (ANTU) injected i.p. from 2 h before to 2 h after the
tumour cells. ANTU specifically increases pulmonary vascular permeability in adult
rats and causes acute pulmonary oedema and pleural effusion. Inhibition of drug
toxicity to the lungs by tachyphylaxis, specific antimetabolites or iodides did not
abolish the effect of ANTU on CFE. CFE was not increased when cells were seeded by
i.v. injection in lungs affected by advanced pulmonary oedema at 6 to 24h after
treatment with the drug. ANTU did not enhance growth of intratracheally injected
cells.
Although ANTU has no cytotoxic or immunosuppressive action, treatment of
tumour-immunized rats with ANTU caused apparent "breakdown" of tumour
immunity in50% of rats, by causing growth of tumour colonies in the lungs.
Possible mechanisms for the ANTU-induced decrease in innate resistance to
growth of tumour in the lungs are discussed.
INNATE susceptibility of the lungs to
clonogenic growth of i.v. injected tumour
cells decreases rapidly in the rat during the
first 2 weeks after weaning (van den
Brenk, Sharpington and Orton, 1973a).
Susceptibility to tumour growth (mea-
sured in terms of tumour-colony-forming
efficiency, CFE) in the lung and other
organs, however, is markedly increased in
grown rats by the induction of states of
topical or systemic stress (van den Brenk
et al., 1976a). Thus, local X-irradiation of
the lungs (van den Brenk et al., 1973b;
Milas and Withers, 1970) injection ofrats
with adrenergic drugs, inflammatory
agents (cellulose sulphate, Compound 48/
80) or chemical convulsants, and physical
restraint of rats (van den Brenk et al.,
1974) markedly increased tumour OFE.
These various stressors cause a perturba-
tion of pulmonary physiology which
appears to provide the milieu propitieux
for survival and growth of seeded tumour
cells. It seemed likely that the common
disturbance in physiology caused by these
stressors was an increase in permeability
of the pulmonary exchange vessels, which
enhanced tumour growth by allowing
plasma, rich in growth-stimulating sub-
stances, to enter the extravascular com-
partment and enhance nidification of the
seeded tumour cells.
In order to test this concept, we have
studied the effects on tumour CFE in the
lungs oftreatment ofratswith the rodenti-
cide, ac-naphthyl thiourea (ANTU), a
compound which induces acute pulmonary
oedema and pleural effusion (Richter,
1945) but has no significant effects on
blood vessels and vascular permeability in
other organs (Richter, 1952; Cunningham
and Hurley, 1972). Related singly N-
substituted derivatives of thiourea which
contain the thioreido (-NHCSNH-)
grouping show similar toxicity to rats
(Dieke, Allen and Richter, 1947). These
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compounds exhibit other pharmacological
characteristics (van den Brenk, Kelly and
Stone, 1976b) which add to their value as
probes for studying tumour CFE in the
lungs of rats. Thus, whereas weanling rats
are highly resistant to their actions on the
lungs, toxicity develops and increases
rapidly during the 5th and 6th weeks of
postnatal development, when innate resist-
ance to tumour growth in the lungs devel-
ops. Also, marked resistance of mature
rats to lung damage from toxic thioureas
can be readily induced by tachyphylaxis
and treatment with iodine and other
agents. The toxicity to the lungs ofANTU
and related toxic thioureas is not mediated
by the thyroid or adrenal glands (van den
Brenk et al., 1976b); these agents do not
inhibit cell replication, and have no
significant effects on haemopoiesis or on
immunological functions. The dosage of
ANTU used to treat rats can be regulated
to induce severe pulmonary oedema and
effusion within a few hours, which rapidly
resolves without causing lasting lung
damage and allows rats to recover fully
with 24-48 h. Advantage has been
taken of these various aspects of the
toxicology of ANTU and related com-
pounds in studying and analysing their
effects on tumour CFE in lungs of rats.
MATERIALS AND METHODS
The techniques used in these experiments
to determine and quantify CFE of i.v.
injected tumour cells in the lungs ofrats have
been described previously (van den Brenk et
al., 1973a), together with the methods used to
prepare lethally irradiated (LI) tumour cells,
to irradiate locally the lungs of rats and to
immunize rats against allogeneic Walker
(W256) tumour. Female CarwAorth Farm rats
of a specific pathogen-free (SPF)-derived
colony were used which were singularly free
from lung infection or other pulmonary dis-
orders. The tumour was passaged as an ascites
tumour and prepared as a cell suspension as
previously described for injection of rats and
quantitative bioassay of growth of tumour
colonies in the lungs. The latter were counted
8 days after i.v. injection of tumour cells in
the unfixed lungs ofexsanguinated rats, w-hen
they wAere macroscopically visible as blood-
red colonies, 1 to 2 mm in diameter.
The principal agent used (1-(1-naphthyl)-2-
thiourea=o-naphthyl thiourea, ANTU, Koch
Light Laboratories) was prepared as a suspen-
sion in olive oil or Mazola oil by sonication,
for i.p. injection of rats. In a previous
publication (vain den Brenk et al., 1976b) the
sources ofsupply, preparation, administration
and effects of other compounds used in these
experiments are described; also the tech-
niques used to perform thyroidectomy and
adrenalectomy, the measurement of pulmon-
ary oedeina and pleural effusion induced by
toxic thioureas, induction of tachyphylaxis,
and the production of resistance to these
drugs by the feeding of rats with potassium
iodide, injection writh specific antimetabolites
or by treatment with agents which modify
toxicity by stimulating the activities of drug-
metabolizing microsomal enzymes. In this
previous paper wAe published data concerning
dosage and age-dependent toxicity of ANTU
and related compounds in the same strain of
rats as that used in the present experiments,
and described the pharmacodynamic actions
of ANTU in causing pulmonary oedema and
the rate of its resolution. The design of the
present experiments on tumour growth has
been very largely influenced by these previous
data, particularly in selecting time intervals
betwAeen injection of rats wAith the drugs and
tumour cells. However, in many of the
tumour experiments, additional control
groups of rats (injected with the agent(s) but
not wTith tumour) wvere included, and killed at
appropriate times to measure the incidence of
pulmonary oedema and pleural effusion, and
to determine the changes in histological
appearances extant at the time ofinjection of
the corresponding groups of rats with tumour
cells.
Intratracheal (i.t.) injection oftumnourcells.-
Tumour cells were counted and dilutions of
106 to 108 cells per ml in Tyrode's solution
(pH 7-3) were prepared for i.t. injection. Rats
were lightly anaesthetized and the skin
covering the anterior neck was shaved. This
area was liberally swabbed with an antiseptic
solution (0.5%0 chlorhexidine in alcohol) and a
small longitudinal incision made through the
skin of the lower neck overlying the cricoid
and upper tracheal cartilages, which were
exposed bydeepening the incision through the
pretracheal musculature. The required num-
ber of tumour cells contained in a volume of
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0-1 ml was drawn up into a Iml syringe,
followed by an additional 0-5 ml of air. The
contents of the syringe were then rapidly
injected, at inspiration, into the upper tra-
chea, entered immediately below the cricoid
cartilage. The syringe was withdrawn and the
skin wound was closed with a single suture. If
the rat was cyanosed it was placed in a
chamber aerated with 95% 02/5% CO2 to
recover. It was then transferred to the X-ray
therapy apparatus described previously (van
den Brenk and Sharpington, 1971) and the
whole of the lower portion of the neck
(including the entire wound) was given a
single dose of 1000 rad X-rays, taking care to
shield the entire thorax and remainder ofthe
body with 3mm-thickleadsheeting. Thispost-
operative treatment of the neck following i.t.
injection with tumour cells was mandatory;
it prevented local recurrence of growth of
solid tumour at the site of injection, which
otherwise invariably occurs and causes
asphyxiation within a week after i.t. injection
ofthe cells. The lungs ofi.t. injected rats were
inspected for macroscopic evidence oftumour
growth, and then placed in buffered neutral
formalin for fixation and the preparation of
serial sections stained with haematoxylin-
eosin for histological examination.
RESULTS
Tumour CFE in ANTU-treated rats
(1) Toxicity ofANTU.-I.p. injection of
grown rats, aged 6 weeks or more, with
5 mg ANTU/kg body wt caused acute
pulmonary oedema and pleural effusion to
appear 2-3 h after injection; the oedema
rapidly increased and reached maximum
intensity at about 4-5 h, and thereafter
over the next 24-48 h it resolved slowly
but completely (van den Brenk et al.,
1976b; see Fig. 1). It was found that over
90% of such older rats given 5 mg/kg
survived, but that death usually occurred
within 8 h when the dose was increased to
10 mg ANTU/kg. A smaller dose of 2 mg
ANTU/kg rarely caused pulmonary
oedema and pleural effusion. In young (3-
to 4-week-old) rats, doses of 10-100 mg
ANTU/kg failed to cause pulmonary
oedema, but subsequently toxicity to the
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FIG. 1.- Tumour CFE measurements in lungs
of 7-week-old rats injected i.p. with 5 mg
ANTU/kg (closed circles) at intervals
before (negative values) or after i.v.
injection with 104 W256 tumour cells.
Also shown are CFEvaluesfor ratsinjected
with ANTU as weanlings and injected with
cells only 52 days later, when aged 7 weeks
(A), or similarly treated weanlings given a
second injection of ANTU immediately
before cells at 7 weeks (A); 7-week-old rats
injected with olive oil (LIn) or saline(O)
only 2 h before cells (6 to 8 rats per point).
Therateofproductionofpulmonaryoedema
(shown as measurements of volume of free
pleural fluid) and its rate of resolution are
shown for 7-week-old rats killed 0, 2, 5, 24
and 48 h after i.p. injection with 5 mg
ANTU/kg (x dotted line, 5-8 rats per
point).
agentdevelopedrapidly duringthe 5th and
6th weeks.
Older rats could be made highly resist-
ant to the toxic effects of ANTU on the
lungs by (1) tachyphylaxis, induced by
injecting rats with small (non-toxic) doses
of ANTU (or other thiourea derivatives)
for a few days before challenge with larger
doses of 5 mg/kg or more, (2) pretreatment
for 4-5 days with iodine or KI added to
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their drinking water, (3) combined injec-
tion of ANTU with I-ethyl-l-phenyl-2-
thiourea (EPTU) or propyl thiouracil
(PTU) which act as specific antimetabol-
ites in antagonizing the toxicity ofANTU
and related toxic thioureas to the lungs.
These effects are described in detail in an
earlier publication (van den Brenk et al.,
1976b) in which it was also shown that the
pulmonary toxicity of ANTU and its
inhibition by tachyphylaxis, iodides and
antimetabolites such as EPTU and PTU,
are not mediated by the thyroid gland and
are not significantly affected by thyroid-
ectomy or by treatment with thyroid or
adrenocortical hormones or by adrenergic
agonists. It is important to draw attention
to our findings thattachyphylaxis could be
induced at an early age in weanling rats,
during a stage of development when the
rat was highly resistant to the toxic effects
ofANTU on the lungs, but sensitive to the
goitrogenic effects of thiourea and other
goitrogens. Such weanlings, pretreated
with low or high doses of ANTU, or with
thiourea, remained resistant for several
weeks to a further challenge with ANTU
in high dosage given when the rats would
have otherwise developed toxicity to
ANTU and related compounds.
(2) Stimulation of CFE; drug dose-effect
relationship.-In young rats, innate resist-
ance to growth of i.v. injected W256 cells
in the lungs is low and tumour CFE is high
(van den Brenk et al., 1973a). Injection of
weanling rats with ANTU in doses of 5 to
50 mg/kg caused no pulmonary oedema
and only slight increases in tumour CFE
when given 2-3 h before the tumour cells.
Similar treatment of older (ANTU-
sensitive) rats with a toxic dose of 4-5 mg
ANTU/kg caused very marked increases in
tumour CFE (Table I, Figs. 1 and 2). A
non-toxic dose of 1 mg ANTU/kg had no
significant effect, but CFE increased with
increase in dose of ANTU (Fig. 2). Treat-
ment of rats with the maximum tolerable
dose (5 mg/kg) caused 100-fold or greater
increases in CFE. The increases in lung
weight measured 8 days after the injection
of ANTU and tumour cells were largely
due to the weight ofgrowing lung tumour
colonies; they were not due to generalized
oedema induced byANTU, which resolved
within the first few days, irrespective of
additional injections with tumour cells.
ANTU did not significantly affect the
weights of thymus and spleen in tumour-
injected rats, and had no effect on the rate
of body growth after the first 24-48 h
(Fig. 2).
(3) Times of injection of ANTU and
tumour cells.-CFE was not significantly
affected in grown rats by 5 mg ANTU/kg
injected 5 days before the tumour cells, but
it progressively increased as this interval
was shortened to 24 h anditincreased even
more steeply as the interval was decreased
from 10 h to zero (Fig. 1).
Maximum increases in CFE were ob-
TABLEI.-Effect ofi.p. o-Naphthyl Thiourea (ANTU) 2 h before i.v. Injection with W256
Tumour Cells on Tumour CFE in the Lungs of Rats ofDifferent Ages, Measured 8 days
Later (6-8 Female Rats per Group)
Age
(weeks)
4
5
8
12
Number of
i.v. injected
W256 cells
103
103
104
104
Dose ANTU
(mg/kg)
nil
10
nil
5
nil
5
nil
4
4*
* ANTU injected 24 h after tumour cells.
7
Number of
lung colonies
29±12
87±27
12±7
135±30
3±2
221± 65
2±1
110±29
6±4
Increase
in CFE
(fold)
3
11
74
55
3
Lumg
weight (g)
1 00±0 05
1*05±0-06
0-98±0-02
1*27±0 07
1*19±0-03
1 60±0*09
1*24±0*05
1-82±0*05
1 52±0-09
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FIG. 2.-Dose-effect curve (closed symbols)
for tumour CFE in lungs of 8-week-old rats
injected i.p. with single doses of ANTU
(mg/kg) 2 h before i.v. injection with 104
W256 tumour cells and killed 8 days later
to count lung tumour colonies, organ wet
weights and rate of body growth (AW/T
g/day); in the 2 groups injected with
tumour cells, no ANTU but an equal
volume of saline (0) or olive oil (A) was
injected (6 rats per group).
tained when ANTU was injected from -2
(before) to +2 h (after) i.v. injection of
tumour cells. CFE rapidly decreased when
ANTU was injected after the tumour cells,
and no enhancement of CFE occurred
when 16 h had elapsed before treatment.
It is stressed that at no time was CFE
enhanced by i.p. injection of rats with the
vehicle (olive oil or Mazola oil) used to
suspend ANTU for i.p. injections. The
presence ofpulmonary oedema in itselfdid
not stimulate survival and growth of the
seeded tumour cells, since no significant
stimulation of CFE occurred when ANTU
was injected at -24 to -5 h, so that the
seeding ofcells occurred when lung oedema
and effusion were both well established.
The maximum enhancement of CFE was
induced byANTU given 2 h before or after
seeding of cells into lung tissue in which
the oedematous change had not yet
developed (Fig. 1). No enhancement of
CFE occurred when ANTU was given to
weanlings 52 days before the tumour cells
were injected. This treatment ofweanlings
with a single large dose of ANTU induced
tachyphylaxis which persisted for several
weeks, so that the second dose of ANTU,
given 2 h before injection with tumour
cells at 11 weeks of age, did not enhance
CFE (Fig. 1).
Trapping of i.v. injected tumour cells
and distribution of tumour colonies were
not affected by ANTU. The great majority
of i.v. injected W256 tumour cells are
trapped in the lungs (van den Brenk et al.,
1975); the aortic blood remains remark-
ably free of i.v. injected tumour cells,
tumour colonies are confined to the lungs,
and neither colonies nor microscopic
evidence of tumour were detected in other
organs when thelungcolonieswere counted
8 days or later after i.v. injection of the
cells.
Tumour growth in ANTU- and thiourea-
resistant rats
(1) Tachyphylaxis.-Pulmonary oedema
and effusion produced in 6-week-old or
older rats by ANTU could be virtually
abolished by pretreatment ofrats on 3 or 4
successive days with smaller doses (0.5 to
2 mg/kg) ANTU (see Fig. 3; van den Brenk
et al., 1976b). Toxicity could be similarly
abolished by pretreatment with small
doses of thiourea. However, rapid induc-
tion of tachyphylaxis in this way failed to
affect significantly the enhancement of
CFE by ANTU (Fig. 3). In further experi-
ments it was found that rats which had
recovered from pulmonary damage
induced by toxic doses of ANTU, and in
which a high degree of resistance to its
toxic actions on the lungs persisted for
several weeks, exhibited greater resistance
to clonogenic growth of tumour cells. The
resistance to tumour growth persisted for
14 days, but thereafter decreased when
rats were retreated with ANTU (Table II),
and despite the fact that a high level of
resistance of the lungs to its toxic action
persisted for at least another 3 weeks.
Desensitization of weanlings with 2 mg
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FIG. 3. Upper curves: Measurements of
tumour CFE in 10-week-old rats injected
i.p. with a challenge dose of ANTU
(abscissa) 2 h before i.v. injection of 104
W256 cells. The rats were given i.v. injec-
tions daily for 4 days of either olive oil
(open circles) or 2 mg ANTU/kg (closed
circles) before the challenge dose of ANTU
and cells were inijected on the following day
(6 rats per point). Lower curves: Left
drug dose-effect data for tachyphylaxis
induced in 10-week-old rats by small doses
of ANTU (abscissa) given daily for 4 days;
all rats were i.p. injected on the 5th day
with 50 mg ANTU/kg and killed 5 h later
to measure pleural effusion (6 rats per point)
Right pleural fluid in 8-week-old rats
5 h after injection with ANTU (abscissa);
no pretreatment (0) or pretreated daily
for 4 davs with 2 mg ANTU/kg (0) or an
equal volume of olive oil (A); 4-5 rats
per point.
ANTU/kg given thrice weekly for 2 weeks
induced complete resistance to the toxic
effects of 5 mg ANTU/kg; although it
significantly reduced its enhancing effect
on tumour CFE from a 70-fold increase in
rats not pretreated with ANTU to a 5-fold
increase in pretreated rats (results not
tabulated) desensitization begun in wean-
lings did not completely inhibit the effect
of ANTU in enhancing tumour growth.
(2) Iodine-induced resistance.-In rats
fed on excess iodine (0.4% KI (w/v) added
to drinking water) for 4 or more days,
toxicity to ANTUwasabolished (Byerrum,
1946; van den Brenk et al., 1976b) as
effectively as by tachyphylaxis. Pretreat-
ment with iodine reduced, but did not
abolish, the enhancement of tumour CFE
induced by ANTU (Fig. 4).
(3) Antimetabolic actions of EPTU and
PTU.-Neither the powerful goitrogen
propyl thiouracil (PTU) nor the competi-
tive antagonist of ANTU, 1-ethyl-l-
phenyl-2-thiourea (EPTU), cause pulmon-
ary oedema, but both compounds inhibit
the toxic action of ANTU and related
compounds to the lungs (van den Brenk
et al., 1976b). EPTU did not significantly
enhance tumour CFE but markedly in-
hibited the enhancement of CFE induced
by ANTU (Table III). PTU caused a
modest but significant enhancement of tu-
mour CFE, but also significantly reduced
the effect of ANTU on CFE when the
2 agents were administered concurrently.
These effects ofPTU and EPTU, alone
or combined with ANTU, on CFE, and of
tachyphylaxis, were not significantly affec-
ted by thyroidectomy (see below) nor by
total or medullary adrenalectomy (results
not tabulated).
Thyroidectomized and adrenalectomized rats
Toxicity to ANTU and resistance to its
toxicity to the lungs induced in rats by
tachyphylaxis, iodine feeding and anti-
netabolite action are not reduced by
thyroidectomy (ThX), total adrenalectomy
(TAX) or medullary adrenalectomy (MA.)
as previously described (van den Brenk
et al., 1976b). Neither TAX nor MAX
affected enhancement of CFE by ANTU
(results not tabulated). Tumour CFE was
not significantly affected by Th. per-
formed 10 days before the i.v. injection
with tumour cells (Table IV). A somewhat
greater enhancement ofCFE was produced
by ANTU in thyroidectomized rats, but
the increase was not statistically signifi-
cant. However, the reduction in effect
of ANTU on tumour CFE caused by
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TABLE II.-Tumour CFE in Lungs of 66 Female Rats Injected i.v. with 104 W256 Cells.
The 3 Groups (A, Band C) werePretreated at 6 weeks ofAge with 2 i.p. Injections of5 mg
ANTU/kg (A) or Olive Oil (B) Given 3 Days Apart, or Received No Treatment (C). A
Further i.p. Injection of 5 my ANTU/kg was Given to Groups A and B (but not C) 7-21
Days Later and 2 h before i.v. Injection with Tumour Cells (6 to 8 Rats per Group)
Interval between ANTU Final mean Number of
pretreatment and i.v. tumour body weight lung Lung weight
cells (days) Group (g) colonies (g)
7 A 219 5±2 1*31±0*10
B 217 450±100 2-13±0-27
C 210 6±3 1*21±0 006
14 A 199 5±2 1-24±0-06
B 214 222±37 1*66±0-09
C 226 12±3 1-36±0-06
21 A 234 130±45 1-65±0-11
B 217 180±42 1-54±0 19
C 230 19±10 1-26±0-04
pretreatment with iodine was greatly
increased byTh,.
Pleuralfluid and anticoagulants
The straw-coloured fluid harvested 5 h
after i.p. injection of 6- to 8-week-old rats
with 5-10 mg ANTU/kg contained 3-4%
total protein, and mesothelial cells and
macrophages were present in low concen-
trations. This fluid was rich in fibrinogen
and rapidly clotted on standing. After
heparinization the pleural fluid was found
to be equally as effective as rat serum or
plasma in supporting growth of W256
tumour cells and normal cells in culture
(to be published). In one assay, rats were
injected i.v. with 103-104 W256 tumour
cells and half of these animals were
treated with 2 i.v. injections of 0 5 ml
freshly harvested ANTU pleural fluid
given 30 min and 2 h after i.v. injection of
the tumour cells. Subsequent lung tumour
colony counts showed that this treatment
with pleural fluid had no effect on CFE. In
afurtherexperiment, inwhichtheratswere
treated with ANTU, the anticoagulant
heparin was administered 10 min before
and again 2 h after i.v. injection of the
tumour. Heparin caused the death of
nearly 50% of the rats, due to peritoneal
haemorrhage. Measurements of tumour
growth in the survivors showed that
heparin did not inhibit, but caused in-
creases in, CFE in both controls and
ANTU-treated rats (Table V).
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FIG. 4.-Effect ofpretreatment of 8-week-old
rats with potassium iodide added to
drinking water (open circles) compared
with control rats (closed circles) on
stimulation of tumour CFE in the lungs
by an i.p. injection with ANTU (abscissa)
given 2 h before i.v. injection with 104
W256 cells on the 5th day (6-8 rats per
point).
Intratracheal seeding of tumour cells
Several attempts have been made to
grow W256 and Y-P388 cells in rats by
i.t. implantation and inhalation in the
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TABLE III.-Effect on Tumour CFE in
the Lungs of Rats of 67 mg Propyl
Thiouracil (PTU)/kg or 50mg 1-Ethyl-I-
phenyl Thiourea (APTU)/kg, Given
Singly or Combined with 5 mg oc-Naph-
thyl Thiourea (ANTU)/kg body weight,
and Injected i.p. 10 min before the i.v.
Injection of 104 W256 Tumour Cells. Six
5-week-old Female Rats per Group were
Used in A and Six 7-week-old Females
per Group in B
Treatment
A 0 2 ml propylene glycol
PTU only
ANTU only
PUT4ANTU
No. of
tumour colonies
2-5±1-5
30 - 5 1- 5
30±8
214±39
125±29
B 0 2 ml propylene glycol 0 5±0i2
EPTU only 2-8±1-3
ANTU only 140±32
EPTU+ANTU 6±4
PTUand EPTUwere dissolved in0 2mlpropylene
glycol for i.p. injections; ANTU was suspended in
olive oil.
laboratory, but our effortsmetwithsuccess
only if very young (2- to 3-week-old) rats
were used which had been injected with
106 or more tumour cells. Even so, CFE
was very low. The successful cell takes
grew very slowly and formed small
tumourfoci consisting ofbranching clumps
of tumour cells which lined the alveolar
sacs and gave rise to a "pneumonic" type
of infiltration. No success was achieved in
grown rats-even if measures had been
taken which greatly enhanced CFE of i.v.
injected cells, namely, whole-body and
local thoracic irradiation, administration
of inflammatory agents such as cellulose
sulphate and Compound 48/80, /3-adrener-
gic agents and other stressors (van den
Brenk et al., 1973a, b, 1974, 1976b). We
have been equally unsuccessful in our
attempts to enhance growth ofi.t. injected
cells by treatment with ANTU (results not
tabulated) under conditions in which
extensive pneumonic consolidation with
protein-rich exudate was induced rapidly
after seeding, which might be expected to
favour nidification and growth of the
seeded tumour cells.
Effect of ANTU on growth of tumour in
extrapulmonary sites
ANTU given i.p. or locally at the site of
implantation in rats s.c. injected with
W256 cells did not affect the number of
cells required to cause tumour growth; the
ED50 value approximated to 5x 102 W256
cells in untreated and ANTU-treated
groups in an assay performed with small
groups of rats (results not tabulated).
Furthermore, corresponding measure-
ments made of lung and kidney tumour
colonies in rats injected i.v. with Y-P388
cells (van den Brenk and Kelly, 1973)
showed that treatment with ANTU en-
hanced CFE in the lungs but caused no
TABLE IV.-Effect of Total Thyroidectomy on Tumour CFE in Lungs of Untreated Rats
and Rats Pretreated with ANTU* only, before i.v. Injection with Tumour Cells, or Fed
on Jodinet for 6 days before Injections with ANTU and Tumour Cellst. Mean Body
Weight (g) BWo (Day of Operation or Mock Operation), BW18 (18 Days Later When
Rats were Killed); 6 Rats per Group
Thyroidectomy
+
+
+
BWo
139
130
133
132
133
134
BW18
185
158
179
156
178
163
BW18-BWo
46
28
46
24
45
29
No. of
tumour colonies
0 7±0 3
1 0±0-2
107±45
151±27
22±8
1-0±0 4
* 5 mg/ANTU kg i.p. 2 h before W256 cells.
t 0.4% KI (w/v) added to drinking water for 6 days before injection ofANTU tumour cells.
t All rats were injected i.v. with 104 W256 cells and killed 8 days later to count lung colonies.
Treatment
with drugs
Nil
ANTU
KI+ANTU
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(a)
(c)
FIG. 5.-Transhilar sections oflungs (stained haematoxylin-eosin) showing incidence, distribution and
size of 8-day-old tumour colonies produced by i.v. injection of 10-week-old rats with 105 W256 cells.
(a) Unimmunized rat not given ANTU (arrow-single colony). (b) Rat immunized with LI cells
(see text) and given 5 mg ANTU/kg 2 h before i.v. tumour cells. (c) Unimmunized rat given 5 mg
ANTU/kg before i.v. tumour cells. The 3 photographs at same magnification.
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TABLE V.-Effect ofTreatment ofRats with
Heparin and ANTU on CFE in the
Lungs Measured 8 days after i.v. Injec-
tion of 5-week-old Rats with 103W256
Cells (6 Rats per Group)
Treatment
I. Nil
II. Heparin
III. ANTU
IV. Heparin + ANTU
No. of tumour
colonies
(No. of rats
in parentheses)
16± 7 (6)
50±27 (4)
731 8 (6)
104±20 (3)
250 iu heparin (i.p.) given 10 min before and 2 h
after i.v. injection of tumour cells. 5 mg ANTU/kg
(i.p.) given 2 h before tumour cells. Two rats (Group
II) and 3 rats (Group IV) died from haemorrhage
following second injection of heparin.
significant change in tumour CFE in the
kidneys (results not tabulated).
Effects of treatment with ANTU combined
with Compound 48/80, aminophylline or
lethally irradiated (LI) tumour cells
Enhancement of tumour CFE in the
lungs induced by ANTU in mature rats
was significantly increased by combined
treatment of rats with aminophylline
(10-5 mmol/g) orwith 100, 200 and 300 jig
Compound 48/80 given on successive days
for 3 days before injection with 5 mg
ANTU/kg, followed 2 h later by i.v.
injection with 103 W256 cells (results not
tabulated). Both aminophylline and Com-
pound 48/80 enhance tumour CFE in the
lungs (van den Brenk et al., 1976b). The
effects of ANTU combined with each of
the 2 agents was essentially additive. A
similar additive effect on CFE was pro-
duced by LI cells added to excess to the
i.v. inoculum of viable tumour cells
(Revesz effect) combined with treatment
with ANTU (results not tabulated).
Effect ofANTU in tumour-immune rats
In rats which had been immunized
against growth ofallogeneic W256 tumour
by 6 i.m. injections of 107 LI (W256) cells
spread over 3 weeks, the further i.v.
injection with 105 intact W256 cells failed
to produce growth of tumour colonies in
the lungs. After pretreatment of the
tumour-immunized rats with ANTU, i.v.
injection of 105 intact cells caused clono-
genicgrowth oftumourin thelungs of50%
of the animals (Table VI). In the immun-
ized rats treated with ANTU in which
clonogenic growth developed, the number
of colonies was greatly reduced. This
caused corresponding decreases in lung
weight (Table VI) also shown by decrease
in volume ofthe fixed collapsed lung (Fig.
5). However, individual tumour colonies
were not significantly smaller than those
in immunized rats (Fig. 5) and showed no
significant histological differences; abun-
tant mitotic figures were present and no
evidence of enhancement of the cellular
reactions commonly associated with tum-
our immunity and spontaneous tumour
regression were observed, such as infiltra-
tion with mononuclear cells (to be pub-
lished). Although the marked enlargement
of lungs of immunized rats treated with
ANTU (Fig. 5b) was partly due to oedema,
the latter was due to growth of colonies in
large numbers and not to oedema from
ANTU, as can be seen by its absence from
TABLE VI.-Effect of 5 mg ANTU/kg i.p. 2 h before i.v. Injection of Rats with 105 W256
Cells: (A) Unimmunized Rats, (B) Rats Immunized against Growth of W256 Tumour
by i.m. Injection with 107 LI (W256) Cells Twice Weeklyfor 3 Weeks (8RatsperG7roup)
No. of
ANTU tumour colonies
A. Not immunized
B. Immunized
+
15±10
500*
0
44586t
* Estimated value: confluent growth of colonies.
t Individual values 0, 0, 0, 0, 5, 15, 84, 250.
Lung wt
(g)
1*10±0-04
4-91±0-71
1 00±0-02
1 11±0*05
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the lungs of immunized rats which were
also injected with ANTU (Fig. 5a).
DISCUSSION
Thiourea and its singly N-substituted
derivatives which contain the thioreido
(-NHCSNH-) grouping are rodenticides
which cause acute and intensive pulmon-
ary oedema by acting specifically on
pulmonary vascular endothelium and in-
creasing its permeability. These drugs do
not affect blood vessels in other organs and
tissues and do not produce the cellular and
humoral changes which typify inflamma-
tion. They are not cytotoxic or cytostatic
agents, do not inhibit cell division and
replication and do not interfere with the
expression of cellular or humoral im-
munity. Furthermore, the pulmonary vas-
cular changes induced by ANTU and
related agents are rapidly repaired and
reversible. Its toxicity to rats is age-
dependent and does not appear during
postnatal development until some weeks
after weaning. A strong resistance to these
drugs can be readily induced by tachy-
phylaxis and pretreatment with iodine or
iodides. The drug action can be blocked by
specific antimetabolites, and has been
shown to be affected also by certain
activators and inhibitors of drug-metabol-
izing mixed-ftinction microsomal enzyme
systems which are probably located in the
target lung tissue (van den Brenk et al.,
1976b).
Our finding that these thiourea deriva-
tives greatly enhance clonogenic growth of
tumour cells in the lungs of older rats in
which marked innate resistance to tumour
growth has arisen during their develop-
ment, is of considerable interest to the
study of local tissue changes which affect
survival, nidification and clonogenic
growth in the lungs ofseeded tumour cells,
particularly in view of the fact that,
whereas toxicity of these agents to the
lungs increases, tumour CFE decreases
with age ofrat.
It is tempting to attribute enhancement
of tumour CFE in the lungs by toxic
thioureas simply to the support, succour
and growth-promoting effects of the large
amounts of plasma which leak from the
damaged vasculature into the interstitium
to such an extent that the great reserve of
function of the lymphatic system for
drainage and removal ofexcess protein and
fluid is exceeded. However, enhancement
of CFE does not appear to depend
simply on the presence and degree of
pulmonary oedema. This is shown by the
data in Fig. 1. When the cells were seeded
16-24 h after treatment with ANTU, the
lungs were grossly oedematous but CFE
did not increase. On the other hand, in
rats made resistant to the toxic effects of
ANTU on the lungs by tachyphylaxis,
treatment with iodide or specific antagon-
ists, no significant oedema developed
following treatment with ANTU, but
enhancement oftumour CFE by the agent
was only partially reduced and never
abrogated (Figs. 3 and 4, Tables II-IV).
The fact that stimulation of tumour CFE
by ANTU was essentially confined to
treatments in which the rats were injected
with agent within a few hours before or
after seeding of the tumour cells suggests
that this effect depends on some perturba-
tion of pulmonary physiology which may
also be the primary event on which the
production of increased capillary perme-
ability depends, and that secondarychang-
es in endothelial cells, which largely fail to
develop in drug-resistant rats, need to
occur before vascular permeability in-
creases. It is tempting to speculate that the
primary phase of drug action may involve
a perturbation of cyclic nucleotide meta-
bolism. Thus, activation of adenylate-
cyclase receptors by /-adrenergic drugs
caused a similar time-dependent enhance-
ment of tumour CFE in the lungs, ofshort
duration (van den Brenk et al., 1976a).
Also, maintenance of raised intracellular
cyclic adenosine 3'-5'-monophosphate (c-
AMP) levels by an inhibitor of phospho-
diesterase, such as aminophylline, not
only enhanced the effect of /-adrenergic
agents (and other topical stressors) on
tumour CFE (van den Brenk et al., 1976a)
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but also that of ANTU. This hypothesis
attributes the various forms of drug
resistance to events which are not con-
cerned so much with the primary compe-
tition between the drugs for receptors, or
with subsequent changes in cyclic nucleo-
tide metabolism, but with changes in the
cellular mechanisms which control pore
sizes in endothelium, i.e. mechanisms
which may be concerned with the control
of contractility ofendothelial cells (Majno,
Shea and Leventhal, 1969) or active
transport across endothelium (Palade,
1953). Neither the toxicity of ANTU to
the lungs nor its stimulation of tumour
CFE are mediated by the thyroid gland.
The partial resistance to ANTU induced
by iodide, which reduced enhancement of
tumour CFE (Fig. 3) was reinforced by
thyroidectomy (Table IV) although no
such effect of thyroidectomy was obtained
with respect to iodide-induced resistance
to toxicity ofANTU to the lungs (van den
Brenk et al., 1976b).
A poor correlation between the induc-
tion of pulmonary oedema by ANTU and
enhancement of tumour growth was
demonstrated further by attempts to
enhance growth of i.t. seeded cells by
induction of pulmonary oedema. It is not
clear why so few i.t. seeded tumour cells
survive, replicate and produce tumour
deposits. Experience with bronchography
in rats has shown that i.t. injected radio-
opaque fluid enters the terminal ramifica-
tions of the bronchial tree very readily
(van den Brenk and Jamieson, 1962); it
rapidly fills and outlines the saccules and
alveoli in normal rats, even if severe
bronchoconstriction has been induced, but
fails to do so if alveolar consolidation has
occurred, as in pulmonary oedema induced
by hyperbaric oxygen. However, in our
experiments the tumour cells were injected
before pulmonary oedema was induced
by ANTU. Histological studies have
confirmed that i.t. injected W256 cells
enter the alveolar air channels, saccules
and alveoli. We have previously attempt-
ed, on several occasions, to enhance take
and growth of i.t. injected tumour cells by
whole-body irradiation, local irradiation of
the lungs, administration of inflammatory
agents, /3-adrenergic drugs and other
stressors treatments which invariably
enhanced CFE of i.v.-injected cells, and
also by exposing rats to high pressure 02
and severe hypoxia to induce lung damage.
In our hands none of these measures
enhanced growth of i.t. seeded tumour
cells. A few scattered foci of consolidative
tumour growth appeared, only in the
lungs of weanlings after i.t. injection with
very large numbers (106 to 107) of W256
cells. Morphological studies of postnatal
growth of the rat lung (Burri, 1974) have
shown that a structural transformation
occurs in the first 3 weeks, when the
alveolar buds develop as a result of out-
growth of secondary septa which accom-
modate a double capillary network. But
it is difficult to attribute any particular
significance to thesemorphological changes
with respect to growth of either i.v. or i.t.
injected tumour cells.
We have previously provided evidence
that innate resistance of mature lung
tissues of the rat to growth of i.v. injected
tumour cells is not due to immunological
factors but to the development of a
physiological situation in which most of
the trapped tumour cells fail to survive,
and succumb within 24 h after seeding
(van den Brenk et al., 1974). The state of
pulmonary oedema induced by toxic
thioureas does not compromise immuno-
logical functions in the host. Nevertheless,
the enhancement of tumour CFE in the
lungs produced by these agents was
sufficiently intense to compete successfully
with a well-established strong state of
immunity, which had been induced against
a highly immunogenic allogeneic tumour,
by causing clonogenic growth oftumour in
500o of rats (Table VI, Fig. 5). A similar
privileged condition for induction of
growth of highly immunogenic tumour
cells in the lungs of tumour-immune rats
has been previously described in rats
treated with the inflammatory agent,
cellulose sulphate (van den Brenk et al.,
1974).
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